Rapamycin and Regulatory T Cells in Renal Transplant Patients: a Two-year Randomized Prospective Study.
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2015
At a glance
- Drugs Sirolimus (Primary) ; Ciclosporin; Mycophenolate mofetil; Prednisone
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- 09 Jul 2012 Planned End Date changed from 1 Mar 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.
- 22 Jun 2011 Planned end date changed from 1 Jan 2011 to 1 Mar 2012 as reported by ClinicalTrials.gov.
- 28 May 2010 Planned end date changed from 1 Aug 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.